From the liver to the blood-brain barrier: An interconnected system regulating brain amyloid-β levels

Journal of Neuroscience Research

Volumn 89, Issue 7, 2011, Pages 967-968

  Sagare, Abhay P ^a   Winkler, Ethan A ^a   Bell, Robert D ^a   Deane, Rashid ^a   Zlokovic, Berislav V ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; AMYLOID BETA PROTEIN; BRAIN PROTEIN; CD36 ANTIGEN; GLEEVAC; IMATINIB; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; BLOOD BRAIN BARRIER; BLOOD VESSEL REACTIVITY; LETTER; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS; SMOOTH MUSCLE FIBER; TRANSCYTOSIS; VASCULAR AMYLOIDOSIS;

ALZHEIMER DISEASE; ANIMALS; BRAIN; HUMANS;

EID: 79955599494     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22670     Document Type: Letter

References (20)

1. Bell RD, Deane R, Chow N, Long X, Sagare A, Singh I, Streb JW, Guo H, Rubio A, Van Nostrand W, Miano JM, Zlokovic BV. 2009. SRF and myocardin regulate LRP-mediated amyloid-β clearance in brain vascular cells. Nat Cell Biol 11: 143-153.
2. Deane R, Du Yan S, Submamaryan RK, LaRue B, Jovanovic S, Hogg E, Welch D, Manness L, Lin C, Yu J, Zhu H, Ghiso J, Frangione B, Stern A, Schmidt AM, Armstrong DL, Arnold B, Liliensiek B, Nawroth P, Hofman F, Kindy M, Stern D, Zlokovic BV. 2003. RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain. Nat Med 9: 907-913.
3. Deane R, Wu Z, Sagare A, Davis J, Yan SD, Hamm K, Xu F, Parisi M, LaRue B, Hu HW, Spijkers P, Guo H, Song X, Lenting PJ, Van Nostrand W, Zlokovic BV. 2004. LRP/amyloid β-peptide interaction mediates differential brain efflux of Aβ isoforms. Neuron 43: 333-344.
4. Donahue JE, Flaherty SL, Johanson CE, Duncan JA3rd, Silverberg GD, Miller MC, Tavares R, Yang W, Wu Q, Sabo E, Hovanesian V, Stopa EG. 2006. RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease. Acta Neuropathol 112: 405-415.
5. Eisele YS, Obermüller U, Heilbronner G, Baumann F, Kaeser SA, Wolburg H, Walker LC, Staufenbiel M, Heikenwalder M, Jucker M. 2010. Peripherally applied Aβ-containing inoculates induce cerebral β-amyloidosis. Science 330: 980-982.
6. 1-40 labels amyloid deposits in the aged primate brain in vivo. Neuroreport 7: 2607-2611.
7. Giri R, Shen Y, Stins M, Yan SD, Schmidt AM, Stern D, Kim K-S, Zlokovic BV, Kalra VK. 2000. β-Amyloid-induced migration of monocytes across human brain endothelial cells involves RAGE and PICAM-1. Am J Physiol Cell Physiol 279: C1772-C1781.
8. Mackic JB, Weiss MH, Miao W, Kirkman E, Ghiso J, Calero M, Bading J, Frangione B, Zlokovic BV. 1998. Cerebrovascular accumulation and increased blood-brain barrier permeability to circulating Alzheimer's amyloid beta peptide in aged squirrel monkey with cerebral amyloid angiopathy. J Neurochem 70: 210-215.
9. Mackic JB, Bading J, Ghiso J, Walker L, Wisniewski T, Frangione B, Zlokovic BV. 2002. Circulating amyloid-beta peptide crosses the blood-brain barrier in aged monkeys and contributes to Alzheimer's disease lesions. Vasc Pharmacol 38: 303-313.
10. Martel CL, Mackic JB, McComb JG, Ghiso J, Zlokovic BV. 1996. Blood-brain barrier uptake of the 40 and 42 amino acid sequences of circulating Alzheimer's amyloid beta in guinea-pigs. Neurosci Lett 206: 157-160.
11. Miller MC, Tavares R, Johanson CE, Hovanesian V, Donahue JE, Gonzalez L, Silverberg GD, Stopa EG. 2008. Hippocampal RAGE immunoreactivity in early and advanced Alzheimer's disease. Brain Res 1230: 273-280.
12. Park L, Wang G, Zhou P, Zhou J, Pitstick R, Previti ML, Younkin L, Younkin SG, Van Nostrand WE, Cho S, Anrather J, Carlson GA, Iadecola C. 2011. Scavenger receptor CD36 is essential for the cerebrovascular oxidative stress and neurovascular dysfunction induced by amyloid-β. Proc Natl Acad Sci U S A DOI: 10.1073/pnas.1015413108.
13. Poduslo JF, Curran GL, Haggard JJ, Biere AL, Selkoe DJ. 1997. Permeability and residual plasma volume of human, Dutch variant, and rat amyloid β protein 1-40 at the blood-brain barrier. Neurobiol Dis 4: 27-34.
14. Sagare A, Deane R, Bell RD, Johnson B, Hamm K, Pendu R, Marky A, Lenting PJ, Wu Z, Zarcone T, Goate A, Mayo K, Perlmutter D, Coma M, Zhong Z, Zlokovic BV. 2007. Clearance of amyloid-β by circulating lipoprotein receptors. Nat Med 13: 1029-1031.
15. Silverberg GD, Miller MC, Messier AA, Majmudar S, Machan JT, Donahue JE, Stopa EG, Johanson CE. 2010. Amyloid deposition and influx transporter expression at the blood-brain barrier increase in normal aging. J Neuropathol Exp Neurol 69: 98-108.
16. Sutcliffe JG, Hedlund PB, Thomas EA, Bloom FE, Hilbush BS. 2011. Peripheral reduction of β-amyloid is sufficient to reduce brain β-amyloid: implications for Alzheimer's disease. J Neurosci Res DOI: 10.1002/jnr.22603.
17. Takuma K, Fang F, Zhang W, Yan S, Fukuzaki E, Du H, Sosunov A, McKhann G, Funatsu Y, Nakamichi N, Nagai T, Mizoguchi H, Ibi D, Hori O, Ogawa S, Stern DM, Yamada K, Yan SS. 2009. RAGE-mediated signaling contributes to intraneuronal transport of amyloid-beta and neuronal dysfuncction. Proc Natl Acad Sci U S A 106: 20021-20026.
18. Ujiie M, Dickstein DL, Carlow DA, Jefferies WA. 2003. Blood-brain barrier permeability precedes senile plaque formation in an Alzheimer's disease model. Microcirculation 10: 463-470.
19. Zlokovic BV, Ghiso J, Mackic JB, McComb JG, Weiss MH, Frangione B. 1993. Blood-brain barrier transport of circulating Alzheimer's amyloid beta. Biochem Biophys Res Commun 197: 1034-1040.
20. Zlokovic BV, Deane R, Sagare AP, Bell RD, Winkler EA. 2010. Low-density lipoprotein receptor-related protein-1: a serial clearance homeostatic mechanism controlling Alzheimer's amyloid β-peptide elimination from the brain. J Neurochem 115: 1077-1089.